325 related articles for article (PubMed ID: 21341396)
1. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition.
Yang YS; Hur MH; Kim SY; Young K
Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
Zhang F; Liu XL; Rong N; Huang XW
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
5. Ovarian reserve is preserved in Behçet's disease.
şahİn A; Karakuş S; Durmaz Y; Yildiz Ç; Aydin H; Cengİz AK
Int J Rheum Dis; 2017 Dec; 20(12):2070-2076. PubMed ID: 26179772
[TBL] [Abstract][Full Text] [Related]
6. Changes of endocrine and ultrasound markers as ovarian aging in modifying the Stages of Reproductive Aging Workshop (STRAW) staging system with subclassification of mid reproductive age stage.
Ding T; Luo A; Jiang J; Du X; Yang S; Lai Z; Shen W; Lu Y; Ma D; Wang S
Gynecol Endocrinol; 2013 Jan; 29(1):6-9. PubMed ID: 22830447
[TBL] [Abstract][Full Text] [Related]
7. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
9. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.
van Rooij IA; Tonkelaar Id; Broekmans FJ; Looman CW; Scheffer GJ; de Jong FH; Themmen AP; te Velde ER
Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
13. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
14. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
15. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of antimüllerian hormone in women with regular menstrual cycles.
Zec I; Tislarić-Medenjak D; Bukovec-Megla Z; Harni V; Kusić Z
Acta Clin Croat; 2010 Dec; 49(4):405-9. PubMed ID: 21830451
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
18. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
[TBL] [Abstract][Full Text] [Related]
20. The effects of uterine artery embolization on ovarian reserve.
Kim CW; Shim HS; Jang H; Song YG
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():172-176. PubMed ID: 27697621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]